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Abstract We have investigated the effects of interleukin (IL)- 
1/3 and IL6 on expression and phenobarbital (PB) induction of 
ethoxyresorufln O-deethylase (EROD) and pentoxyresorufln O- 
deethylase (PROD) activities, as well as on mRNA levels of 
cytochromes P450 (CYP) 1A, 2B, 2C, 2E and 3A, in rat hepato- 
cytes in primary culture. IL6 slightly antagonized PB-induced 
PROD activity. Strikingly, ILIiB strongly Inhibited basal EROD 
and PROD activities, and fully blocked their induction by PB in 
a dose-dependent fashion. Furthermore ILl# completely sup- 
pressed PB Induction of all CYP mRNAs analyzed. Our results 
demonstrate hat ILI/I can suppress basal CYP activities, as well 
as PB-indueible expression of five CYP mRNAs in rat hepato- 
eytes in primary culture. 
Key words: Adult rat hepatocyte; Cytochrome P450; 
Phenobarbital; Cytokine; Interleukin-l,8; Interleukin-6 
1. Introduction 
Regulation of cytochrome P450 (CYP) gene expression is 
under complex regulatory control in mammalian liver. Not 
only do age, sex, and genetic polymorphisms influence CYP- 
mediated rug metabolism in the liver, but also health status 
as well as exposure to xenobiotics play critical roles. Indeed, 
expression of CYP genes from the four major families is induc- 
ible both in rive and in vitro by a large variety of compounds, 
typified by polycyclic aromatic hydrocarbons (PAH) such as 
3-methylcholanthrene (3-MC), barbiturates like phenobarbital 
(PB), glucocorticoids and fibrates. 
It has recently become clear that infection and inflammation 
diseases generally depress CYP activity in rodents and humans 
[1-3]. We, and others, have demonstrated that individual cyto- 
kines can lower expression of several CYP genes when directly 
added to primary human and rodent hepatocytes or hepatoma 
cells in culture [4-6]. Therefore, decreased CYP activities in the 
liver can be attributed, at least in part, to the direct effect of 
cytokines on hepatocytes. 
Recently, the relationship between cytokines and CYP in- 
ducers on modulating CYP expression has been put into ques- 
tion. 3-MC-mediated induction of CYPIAI and CYPIA2 
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genes in primary rat hepatocyte cultures was shown to be sup- 
pressed, at the transcriptional level, in response to interleukin 
(IL)-Ip, but not to IL6 [7]. It has also been reported that 
epidermal growth factor and transforming rowth factor 
(TGF)-0c blocked 3-MC-induced expression of CYPIAI, in 
mouse hepatocytes in culture [8]. We recently demonstrated 
that TGFpl was able to fully suppress 3-MC induction of the 
CYPIA! and IA2 genes in human hepatocytes in primary 
culture, whereas ILlp, tumor necrosis factor (TNF)-0~ and in. 
terferons (IFN) 0~ and 7 were only slightly active [9]. IL6 was 
shown to inhibit 3-MC induction of CYPIAI in human 
hepatoma cells at the transcriptional level [10], and PB induc- 
tion of CYP2B genes in rat hepatocytes in primary culture [i 1]. 
In addition, ILl,0 could inhibit CYP4AI gene induction by 
fibrates and dexamethasone i  fetal rat hepatocytes [12]. IFN 
inducers were able to counteract p-naphtoflavone-mediated 
ethoxyresorufin O-deethylase (EROD) induction in rive [13]. 
Importantly, growth hormone (GH) was also able to antago- 
nize CYP induction by PB in the rat in rive and in vitro [14,15]. 
However, GH levels did not appear to be the primary determi- 
nants of the acute phase suppressien of CYP gene expression 
in rat hepatocyte cultures, since the effect of cytokin,~s was 
readily observed in absence of added GI-! [7]. Therefore, several 
categories of peptide hormones, presumably upon interaction 
with their specific membrane receptor(s) [5], are able to antag- 
onize induction of CYP genes in response to distinct, structur- 
ally unrelated, inducing compounds. Moreover, TPA, an acti- 
vator of protein kinase C, was shown to antagonize PB-medi- 
ated induction of selected CYP enzymatic activities [16], as well 
as 3-MC induction of CYPIAI gene expression i  rodent and 
human hepatocytes ([17], and unpublished observation i our 
laboratory). Taken together, these observations strongly sug- 
gest that signals initiated at the cell membrane can affect CYP 
induction, possibly through induction of kinase pathways. The 
goal of the present experiments was to extend investigations 
aimed at better understand, especially at the mRNA level, the 
interelations between 'classical' CYP inducers and several cy- 
tokines playing important roles during the inflammatory re- 
sponse. 
The results reported here demonstrate hat ILl,//but not IL6 
can suppress the PB-mediated induction of five distinct CYP 
gene family/subfamily members, i.e. IAI, 2B1/2, 2C6/7, 2El 
and 3Al/2 enzyme activities and/or mRNAs in primary rm 
hepatocyte cultures. 
2. Materials and methods 
2. !. Recomb&ant cytok&es and chenTicals 
Human recombinant ILIp and IL.6 were purchased from Genzyme 
(Cambridge, UK). Several independent batches of ILl,0 were used 
through the one year period covered by this study, and cndotoxin 
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cont_amination was below the detection limit, according to the manufac- 
turer's data sheet. Nicotinamide, 7-ethoxyresorufin, pentoxyresorufin, 
3-MC and PB were from Sigma (St. Louis, Me, USA). 
2.2. Cell isolation and culture 
Adult hepatocytes were obtained after perfusion of male rat liver 
(Sprague--Dawley; 150-200 g) with 0.025% collagenase solution 
(Bc~:hringer-Mannheim) buffered with 0.1 M HEPES (pH 7.4), as pre- 
viously reported [18]. 
Cell viability, estimated by Trypan blue exclusion, ranged between 
80% and 90%. Hepatocytes were seeded on plastic dishes at a de~tsity 
of 63 × 103 per cm= in a standard medium, consisting of 75% (v/v) 
Minimum Essential Medium (MEM) and 25% (v/v) Medium 199, buff- 
ered with 0.22% (w/v) sodium bicarbonate and supplemented with 10 
,ug/mi bovine insulin, I mg/ml bovine serum albumin, 10% (v/v) fetal 
calf serum (FCS) and 1% (w/v) streptomycin. At the first medium 
renewal (4 h at~er seeding), FCS was withdrawn and hydrocortisone 
hemisuocinate nd nicotinamide were added at concentrations of I/~M 
and 10 raM, respectively, Nicotinamide isknown to favor maintenance 
of differentiation fhepatocytes in primary culture [19]. Cytokines and 
inducers were added 24 h after seeding, at the second medium renewal. 
The medium was then changed every day. 
The cytokines have previously been found to regulate basal cyto- 
chrome P, s0 expression in primary cultured human hepatocytes [4,9] 
and/or acute-phase protein expression i both rat and human hepato- 
cytes in primary culture [20,21], At concentrations u ed none of th~ 
cytokines induced mot'phological alterations. 3-MC was dissolved in 
DMSO and was added at the concentration of5 juM which was found 
to ~ optimal for induction of EROD activity, although quite as strong 
an induction was observed for 0.5,uM. No further induction of EROD 
aCtivity was obtained for 10.uM 3-MC. All culture conditions included 
0.2% DMSO, a concentration having no influence on CYP expression. 
2.& Isolation of RNA and blot analysis 
Hepatocyte monolayers were scraped in O. 1 M phosphate-buffered 
saline (PBS). Total RNA was prepared as previously described [22], 
dissolved in sterile water and stored at -80°C. For RNA blotting, 10 
#g of each RNA sample were subjected to electrophore~is in adenatur- 
ing 6% (v/v) formaldehyde-1.2% (w/v) agarosc gel, and transferred onto 
Hybond-N ÷ nylon filters (Amersham, Arlington Heights, IL). Equal 
RNA sample loading and integrity were routinely ascertained by ethid- 
ium bromide staining of minigels, and filters following transfer. Ptehy- 
bridization, hybridization aud washes were pc~rfomted at;cording to 
Church and Gilbert [23]. eDNA probes were riP-labeled by random 
priming using a multiprime labeling kit (Amersham, Arlington Heights, 
IL). Filters were autoradiographed at -80"C. Hybridization signals 
were quantified by densitometry and integration ofunsaturated signals. 
References for CYPlAI (full-length rabbit eDNA (LM4) probe), 2Bll 
2B2 (full-length rat CYP2BI eDNA probe), CYP2C6/2C7 (partial 1200 
bp eDNA fragment from the 3 ° half of the rat mRNA), CYP2EI (full- 
length rat eDNA probe), CYP3AII3A2 (full-length rabbit 3A eDNA 
(LM~) probe) are 24, 25, 26, 27 and 28, Chicken 81yceraldehyde 
3,phospbate d hydrogenase (GAPDH) was used as a control. The 18S 
probe was a human genomic DNA fragment. 
2,4, Ethoxyreson~in O.deethylase and pentoxyresorufin O.deethylase 
activity assays 
EROD and PROD activities, mainly supported by CYPIA and 
CYP2B subfamilies, respectively, were measured essentially according 
to Burke and Mayer [29,30], with slight modifications for living hepato- 
¢yte monolayers [31]. Briefly, the medium was removed after 12, 24, 72 
and 96 h of treatment, and cells were washed with 100 mM PBS and 
then incubated with ethoxyresorufin or pentoxyresorufln (50/~M) and 
udi~lamide (I.5 raM) in PBS at 37"C, Kinetic reading with a spec- 
trofluorimeter was performed over 15 min. Fluorescence values were 
converted to pmoles with a calibration curve of resorufln fluorescence 
and expressed per m8 oftotal protein and per min, PROD activity levels 
m our cultures agreed well with results from in rive and other in vitro 
studies [32,33], although they were on the lower side in some experi- 
ments. 
ZS. Sta, istical analysis 
Comparisons were performed with the Student's t-test following 
ANOVA. in Fig. I and Table ! (upper atrt), the Student's t-test was 
used to perform analysis on each experiment by comparing, for each 
condition, 8 repeated eterminations of EROD and PROD activities 
on the same cell population. In Table 1 (lower part), the analysis 
compares the means of 3-5 independent experiments, performed with 
cell preparations obtained over a one year period. 
The densitometry analysis of RNA blotting/hybridization experi- 
ments was performed with hybridization signals obtained from 7 inde- 
pendent cell preparations for ILIp and 4 independent cell preparations 
for IL-6, without normalization toanother message, since hybridization 
to the 18S probe demonstrated similar loading levels. As anticipated, 
variations were observed between absolute values of the signals, since 
the RNA preparations and hybridization experiments were performed 
independently. The effect of ILl,0 on CYP mRNA levels was analyzed 
with Wiicoxon's test using densitometric values. Significance was set at 
a limit of less than 5%. The specific sets of comparisons are described 
in the legends to figures. 
3. Results 
We set out to investigate the effects of ILl,0 and IL6 on 
phenobarbital induction of CYP.dependent enzyme activities 
Table ! 
Effects of ILl,0 and 11.6 on induced EROD and PROD activities (dose- 
response) 
Condition Activity PROD EROD 
(U/ml) (pmollmg (pmol/mg 
protein/min) protein/min) 
Control 0.44 + 0.19 19.33 + 1.87 
ILl,8 100 0.14 ± 0.10 ### 7.30 + i.46 ### 
IL6 50 0.53 + 0.13 19.53 + 1.15 
PB !.91 + 0.23 ### 104.40 + ! 1.48 ### 
PB + ILlp 1 1.89 + 0.48 75.83 + 15.33 ~ 
I0 1.29 ± 0.27 ~ 55.84 ~: 9.52 ~ 
100 0.58 + 0.20 ~ 30.50 + 3.92 ~ 
500 0.23 + 0.21 t~ 17.55 + 2.68 ~ 
PB + IL6 250 2.25 + 0.47 119.14 + 16.63 
50 1.66 ± 0.29 83.66 ± 7.83 ~ 
Control 0.52 + 0.13 14.62 + 2.85 
ILl,0 100 0.15 + 0.05** 6.57 + 2.90** 
IL6 50 0.53 + 0.13 17.36 + 4.61 
PB !.67 + 0.29*** 79o17 ± 18.62"** 
PB + ILlfl 100 0.42 + 0.22 m 23.59 ± 9.01 u'* 
PB + IL6 50 1.35 :!: 0.24 n'** 67.06 ± 15.50"* 
MC 1.24 + 0.05** 71.18 2:6.80 *t 
MC + ILIp 100 0.72 + 0.09 bb 46.23 ± 2.14 b'*** 
MC + IL6 50 1.27 + 0.03* 61.50 + 1.32"* 
Primary hepatocyte cultures were treated with ILIp (1 to 500 Ulml) or 
!1,6 (up to 250 U/ml, only results with doses of 50 and 250 U/ml are 
shown) in combination with 3-MC (5#M) or PB (2 mM) for 96 h, from 
24 h after seeding. In the upper part, the dose-response analysis was 
performed on cells from a single animal. Each value represents the 
mean + S.E.M. of 8 samples. For EROD and PROD activities, 
ANOVA analysis for all culture conditions on the same animal has been 
performed (P = 0.000 I) before performing the Student's t-test. Statisti- 
cally different from control, untreated cells (Student's t-test, 
#,,wp • 0.001, ##P • 0.01 and °P • 0.05). Statistically different from 
PB-treated cells (Student's t-test, sP • 0.001 and 0p • 0.01). In the 
lower part, each value represents he average of 5 experiments (5ani- 
mals) + S.E.M, except for 3-MC alone or in combination with ILIp 
(3 animals) and 3-MC + IL6 (2 animals). In each experiment neasure- 
taunts were repeated at least 8 times. Control refers to cells kept in 
culture for the same time as treated cells. Statistically different from 
control, untreated cells (Student's t-test following ANOVA (P • 0.05), 
***P • 0.001, **P • 0.01 and *P • 0.05). Statistically different from 
PB-treated cells (Student's t-test, a'aP<0.001, "'P<0.01 and 
"P • 0.05). Statistically different from 3-MC-trcated cells (Student'3 
t-test, bbp < 0.01 and bp • 0.05). 
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Fig. 1. Time-c,,urse analysis of ILl,6 effects on PB-induced EROD (2a) and PROD (2b) activities. Primary rat hepatoeytes were treated with ILI,B 
(100 U/ml) in combination with PB (2 rnM) for 12, 24~ 72 and 96 h, from ?.4 b .~fter seeding. Control r.e~rs ,*c~ cells kept in culture for the same time 
as ~.reated ceils. II.I refers to ILIp. Each value represents the mean _+ S.E.M. of 8 samples. (3', 2', *)Statistically different from the corresponding 
control, untreated cells (Student's t-test following ANOVA (P < 0.0S), (3*)P < 0.001, (2*)P < 0.01, and (*)P < 0.05). (3a, 2a, a)Statistically different 
from PB-treated cells (Student's t-test; (3a)P < 0.001, (2a)P < 0.01 and (a)P < 0.05). 
in primary rat hepatocyte cultures. Cytokines were chosen ac- 
cording to known effects on either CYP expression or acute 
phase protein production by human and rodent hepatocyte 
primary cultures [4,9,20,21]. No apparent cytotoxicity was ob- 
served in response to the cytokines alone or in combination 
with the inducers. 
3.1. Effect of ILI~O and IL6 on basal and induced PROD and 
EROD activities 
The dose-response experiment inTable I (upper part) shows 
that PB induced PROD activity by at least 4-fold (P < 0.001) 
and, as reported in several previous studies [34-36], EROD 
activity by a factor of at least 5 (P < 0.001). ILl,0 was able to 
depress both basal and PB-induced activities in a dose-depend- 
ent manner. Complete inhibition of induction was obtained for 
500 U ILl,0/ml (P < 0.001), while I U ILlp/ml induced apartial 
block of only EROD activity (27%; P < 0.01). In this dose- 
response xperiment, IL6 (50 U/mi) was able to partially block 
the PB-induced EROD activity by an average of 25% 
(P < 0.001) and had no effect on PB-induced PROD activity. 
Table 1 (lower part) shows results from five additional inde- 
pendent experiments at optimal exposure times. PB induced 
EROD and PROD activities by 5.4- and 3.2-fold (P < 0.001), 
respectively. ILl,6 produced rops in basal EROD (55%) and 
PROD (71%) activities, whereas IL6 did not have any signifi- 
cant effect. ILIp blocked PB induction of EROD (P < 0.01) 
and PROD activities (P < 0.001) by 70% and up to 100%, 
respectively. Through all analyzed animals, IL6 did not have 
any significant effect on EROD induction, although it pro- 
duced a 20% decrease of PROD activity (P < 0,05). 
3.2. Ef.I'ect of lLlp on PB-induced PROD and EROD activities: 
time.course analysis 
In order to determine the kinetics of ILl,0-mediated epres- 
sion of PROD and EROD activities under both basal and 
PB-',reated conditions, we conducted a time-course analysis. 
Fig. l a shows that PB induction of EROD activity was detected 
only after 24 h. it was largest after 96 h (4.2-fold; P < 0.001), 
timc; at which basal activity had dropped by 52%° as compared 
to its value at 12 h. ILl,6 (100 U/ml) was able to induce large 
decreases (57-78%; P < 0.001) in basal EROD activity, and this 
effect was already observed as soon as at 12 h of culture. ILI,6 
fully blocked PB induction; at 24 and 72 h, but only by 57% 
(P < 0.001) at 96 h. However, a higher concentration of ILI~0 
(500 U/ml) fully prevented any induction at 96 h (see above). 
Fig. lb shows that PB induction of PROD activity was only 
observable after 72 h of treatment (I.3- to 3.3-fold: P < 0.001 ). 
At these later time-points, full blockades in induction were 
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Fig, 2, Effects of I LI~ and IL6 on PB.induced CYPIAI, CYP2BII2B2, 
CYP2C6/2C?, CYP2EI and CYP3AII3A2 mRNA, Primary rat hepa- 
tocyte cultures from 7 animals were treated with ILIp (100 Ulml), IL6 
(50 U/ml) and PB (2 raM), When cytokines were combined with PB, 
their addition was concomitant, Total RNA was prepared after 96 h 
of treatment and CYP mRNA expression was analyzed by RNA blot. 
Filters were hybridized with s2P-labeled DNA probes and autoradi- 
ographed. C: Control refers to cells kept in culture for the same time 
as treated cells. Hybridization oftbe same filters with 18S and GAPDH 
DNA probes was used as a control. Results from 2 experiments are 
shown in parts a and b. 
obtained in response to ILl`0 (P< 0.001). In addition, ILl`0 
decreased basal PROD activity after 24 h (259{,, P < 0.001) to 
a .~inimum after 96 h (809t; P < 0.001). 
Earlier time-points and a concentration of 250 Ulml of IL6 
have also been surveyed. The effect of this cytokine on EROD 
and PROD activities was similar for both 72 and 96 h time- 
points regardless of the dose (data not shown). 
3,3, Depression of PB.induced levels of CYPI A, -2R -2C -2E 
and ..*A mRNAs by 11.1` 0 
In order to determine if ILI,8 was able to also affect accumu- 
lation of CYP mRNAs contributing to EROD and PROD 
activities, as well as that of other CYP mRNAs, we performed 
hybridization experiments with specific eDNA probes for 
CYPIAI, -2BII2B2, -2C6/2C7, -2El and -3AII3A2. As a 
whole, seven experiments were performed, allowing us to apply 
a statistical test (Wilcoxon), following densitometry and inte- 
gration of unsaturated hybridization signals. Autoradiograms 
from two independent hybridization experiments from two sap. 
arate cell populations are shown in Fig. 2. 
A strong induction of all CYP mRNA signals was observed 
in response to PB. in addition, a faint signal corresponding to
what might be CYPIA2 mRNA (smaller-sized transcript) was 
observed in the PB sample upon hybridization with the 
CYPIAI eDNA probe. However, since this band co-migrated 
with the 18S ribosomal RNA band, it is also possible that it 
represents an artefact due to trapping of some CYPIA I mKNA 
highly abundant in these lanes. 
After densitometric analysis of autoradiograms from the 
7 experiments, the Wilcoxon test was applied to determine the 
significance l vel of IL 1`0 effects. ILl`0 could significantly, albeit 
slightly, decrease basal CYP2C617 (26%; P<0.05) and 
CYP2EI (34%; P < 0.05) mRNA levels through all of the seven 
experiments, although this was not visually apparent in Fig. 2. 
The effect of ILl`0 on basal accumulation levels of CYPIAI and 
CYP2BII2B2 was not significant. This cytokine produced, 
however, about 55% reduction of the PB-induced CYPIAI 
(induction factor of 7.6-fold) and CYP2BII2B2 (induction fac- 
tor of 3.4-fold) mRNA levels (P < 0.05). PB-induced CYP2C61 
2C7 and CYP3AII3A2 mRNAs (induction factors of 2.6- and 
2.l-fold, respectively) were suppressed by 63% and 58% by 
ILl`O, respectively (P < 0.05). CYP2EI mRNA level was in- 
duced by 2.4-fold in response to PB, and this induction was 
reduced L~y 44% by [LIp (P < 0.05). 
Significance l vels of the effect of IL6 on CYP mRNA accu- 
mulation could not be accurately determined due to the limited 
number [4] of independent experiments, even though apparent 
decreases ofthe PB response were generally observed. GAPDH 
mRNA levels did not show substantial variations under the 
various conditions. Finally, hybridization to an 18S ribosomal 
DNA probe demonstrated quivalent RNA loading. 
3. Discussion 
The present study .shows that ILl`0 but not IL6 was able to 
decrease basal EROD and PROD activities in rat hepatocytes 
in primary culture. The effect of cytokines on basal mRNA 
accumulation levels was not always accurately measurable in
the absence of inducer treatment, due to a very low expression 
level. In a previous tudy, we found that ILl`O, IL6 and TNF~ 
suppressed basal CYP mRNA levels in cultured human hepato- 
cytes [4]. ILl`0 could significantly, although modestly, lower 
basal mRNA accumulation levels of CYP2C and CYP2EI 
throul~hout the 7 experiments conducted in the present study. 
As previously described in various other model systems 
[34,35,37-40], PB was able to induce EROD activity, as well as 
CYPIAI mRNA level. We also observed induction in hepato- 
cytes cultured in Williams' E medium (data not shown). In 
addition, ILl`0 was able to strongly antagonize this induction 
as well as PB-induced PROD activity and CYP2BI/2, -2C6/7, 
-2El and -3AI12 mRNAs through 7 independent experiments. 
The effects of ILl`0 and IL6 on the 3-MC-mediated induction 
of EROD and PROD activities agree with previous work [7]. 
No significant effect of TNF0c, IFN0~ or IL4 on basal or PB- 
induced EROD and PROD activities was observed (data not 
shown). However, IFN~, was able to depress basal as well as 
PB-induced EROD activity by an average of 15% (P < 0.01) 
(data not shown). 
In the present study, we observed that IL 1,0, but not I L6, was 
able to fully antagonize 3-MC-mediated induction of EROD 
activity. These observations were in perfect agreement with 
results from Barker et al. [7] who showed, in addition, that the 
antagonism of ILl`0 over induction took place at the transcrip- 
tional level. We made the unexpected observation that 3-MC 
was also able to reproducibly induce PROD activity, although 
no such inductive ffect was observed for CYP2B mRNA (data 
not shown). Further investigations are needed to explain this 
effect which was also blocked by ILl`0. 
Although IL6 was able to slightly suppress PB-inUuced 
EROD level in the dose-response experiment (Table I, uppe~ 
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part), this cytokine depressed only PB-induced PROD activity 
(20%; P < 0.05) over a set of 5 experiments (Table 1, lower 
part). Nevertheless, we did not observe the total blockade of 
CYP2B-associated enzyme activity level reported by others 
using the similar dose range of IL6 in Fisher 344 rat-derived 
hepatocytes cultured on matrigel [11,41]. In addition, no effect 
of IL6 on CYP2B mRNAs could be proven to be significant, 
although a tendency towards decrease was generally seen. 
However, similar results with regard to the effect of ILI.O on 
enzyme activity levels were obtained in this study [41] and in 
ours, 
The mechanism(s) by which ILI.O down-regulates basal and 
induced CYP expression remain(s) unclear. However, another 
peptide hormone, namely growth hormone, has been shown to 
be a strong suppressor of CYP gone induction by PB in vivo 
in the rat and in rat hepatocytes in primary culture, presumably 
upon interaction with its membrane receptor [14,15]. Activa- 
tion of APl and/or NFkB, two major transduction signal effec- 
tors known to be activated by ILl,0 in various systems, remains 
to be analyzed [42,43], 
A potential inhibitory pathway of CVP gone expression 
could involve an increase in nitric oxide (NO) synthase. Indeed, 
it has been recently demonstrated that rat and human CYPl A 
expression was inhibited by NO in recombinant V79 Chinese 
hamster cell lines and in rat hepatocytes. In addition, inhibition 
of NO synthesis, in the presence of cytokines and endotoxin, 
led to restoration of CYPIA! activity [44]. Other studies 
showed induction of NO synthase following treatment with a 
combination of different cytokines (ILl,O, TNFcx and IFNT'), 
which acted synergistically on hepatocytes and other cell types 
[45,46]. Administration of lipopolysaccharide (LPS) diminished 
PB-mediated PROD induction in vivo in the rat, and PB induc- 
tion was partially restored when a specific NO synthase inhib- 
itor was given to animals concomitantly with LPS [47]. In addi- 
tion, glucocorticoids, at a concentration similar to that found 
in our cell culture medium., have been shown to inhibit NO 
synthase induction eilicited by a combination of ILl.o, TNF0~, 
IFN~, and LPS in primary cultures of rat hepatocytes [48]. This 
observation suggests that NO synthase activity might not be the 
main determinant of the effect of ILI.O on PB-mediated induc- 
tion CYP genes. Moreover, preliminary data from our labora- 
tory suggest hat ILI.O suppresses PB induction of CYP genes 
as effectively in presence of an inhibitor of NO synthase (N- 
methyI.L-arginine) as in its absence (data not shown). 
in summary, our results upport he idea that cytokines, and 
especially ILI~, are major regulators of phase ! detoxication 
enzymes. Their effects on phase il enzymes remain to be inves- 
tigated. The observation that cytokines can antagonize CYP 
induction suggests that the overall hepatic detoxication activity 
results from a balance of major inductive and suppressive 
mechanisms. 
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